In utero exposure to a high-fat diet reprograms the liver, leads to long-term gene dysregulation, and ultimately to metabolic disease, according to the results of an animal study recently published in Endocrinology. Researchers led by Maureen J. Charron, PhD, of Albert Einstein College of Medicine in the Bronx, N.Y., point out that it’s already known...
The Endocrine Society has signed on as a partner to JDRF’s Coverage2Control campaign, calling on insurance companies to provide better health coverage for the 1.25 million Americans living with type 1 diabetes. Coverage2Control, launched in May, has the support of more than 52,000 people who have signed JDRF’s petition urging insurance companies to provide coverage...
Study finds higher risk and earlier diagnosis of diabetes in women with PCOS Women who have polycystic ovary syndrome (PCOS) have a higher risk of developing type 2 diabetes (T2D) and are diagnosed at an earlier age with the condition, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. The...
The results show that continuous glucose monitoring is an effective diabetes management tool that could benefit millions of people with type 2 diabetes on insulin therapy People with type 2 diabetes on a multiple daily injection (MDI) insulin therapy benefit from the use of continuous glucose monitoring (CGM), according to a study recently published in...
Inflammatory processes in the liver lead to elevated cholesterol levels in people with diabetes, thus promoting subsequent vascular diseases, according to a study by researchers at Helmholtz Zentrum München, Technische Universität München (TUM) and the Collaborative Research Center SFB 1118 at Heidelberg University Hospital. The paper was recently published in Cell Reports. “Even if blood...
A new study uncovers potential links between secondhand smoke and type 2 diabetes and obesity. Fortunately, the number of smokers is on the decline, but will that reduce rates of diabetes and obesity? The association between smoking and risk factors for respiratory, cardiovascular, and metabolic diseases is widely documented, as are the respiratory and cardiovascular...
Losing weight reduces the risk of long-term cardiovascular illness and mortality for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to dramatically worse outcomes, according a study published recently in The Lancet Diabetes & Endocrinology. Researchers led by James H. Faghmous, PhD, chief technology officer at...
An endocrinologist and cardiologist teamed up to create an entertaining and easily understood method to educate patients. The result is Doctablet, a series of online animations that patients of all ages, backgrounds, and education levels can comprehend and even enjoy. A lack of quality time with patients is a problem in endocrinologists’ offices — and...